L-092-2012
Agreement ID
L-092-2012
Lead IC
NCI
Exclusivity
Exclusive
External Party
Admune Therapeutics LLC, Scott Brown
Fiscal Year
2017
Territory
Worldwide
Execution Date
Effective Date
Export Date
Technologies